The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review
Abstract
Importance: Approximately 125 million people worldwide have psoriasis. Patients with psoriasis experience substantial morbidity and increased rates of inflammatory arthritis, cardiometabolic diseases, and mental health disorders. Observations: Plaque psoriasis is the most common variant of psoriasis. The most rapid advancements addressing plaque psoriasis have been in its pathogenesis, genetics, comorbidities, and biologic treatments. Plaque psoriasis is associated with a number of comorbidities including psoriatic arthritis, cardiometabolic diseases, and depression. For patients with mild psoriasis, topical agents remain the mainstay of treatment, and they include topical corticosteroids, vitamin D analogues, calcineurin inhibitors, and keratolytics. The American Academy of Dermatology-National Psoriasis Foundation guidelines recommend biologics as an option for first-line treatment of moderate to severe plaque psoriasis because of their efficacy in treating it and acceptable safety profiles. Specifically, inhibitors to tumor necrosis factor α (TNF-α) include etanercept, adalimumab, certolizumab, and infliximab. Other biologics inhibit cytokines such as the p40 subunit of the cytokines IL-12 and IL-23 (ustekinumab), IL-17 (secukinumab, ixekizumab, bimekizumab, and brodalumab), and the p19 subunit of IL-23 (guselkumab, tildrakizumab, risankizumab, and mirikizumab). Biologics that inhibit TNF-α, p40IL-12/23, and IL-17 are also approved for the treatment of psoriatic arthritis. Oral treatments include traditional agents such as methotrexate, acitretin, cyclosporine, and the advanced small molecule apremilast, which is a phosphodiesterase 4 inhibitor. The most commonly prescribed light therapy used to treat plaque psoriasis is narrowband UV-B phototherapy. Conclusions and Relevance: Psoriasis is an inflammatory skin disease that is associated with multiple comorbidities and substantially diminishes patients’ quality of life. Topical therapies remain the cornerstone for treating mild psoriasis. Therapeutic advancements for moderate to severe plaque psoriasis include biologics that inhibit TNF-α, p40IL-12/23, IL-17, and p19IL-23, as well as an oral phosphodiesterase 4 inhibitor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nestle, F. O., Kaplan, D. H., & Barker, J. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804595 · Cited by 2,786
Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence
Parisi, R., Symmons, D. P. M., Griffiths, C. E. M., & Ashcroft, D. M. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.339 · Cited by 2,592
Secukinumab in plaque psoriasis—results of two phase 3 trials
Langley, R. G., Elewski, B. E., Lebwohl, M., Reich, K., Griffiths, C. E. M., Papp, K., Puig, L., Nakagawa, H., Spelman, L., Sigurgeirsson, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314258 · Cited by 1,997
Risk of myocardial infarction in patients with psoriasis
Gelfand, J. M., Neimann, A. L., Shin, D. B., Wang, X., Margolis, D. J., & Troxel, A. B. (2006) · JAMA · doi:10.1001/jama.296.14.1735 · Cited by 1,899
Leonardi, C. L., Kimball, A. B., Papp, K. A., Yeilding, N., Guzzo, C., Wang, Y., Li, S., Dooley, L. T., & Gordon, K. B. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60725-4 · Cited by 1,874
Papp, K. A., Langley, R. G., Lebwohl, M., Krueger, G. G., Szapary, P., Yeilding, N., Guzzo, C., Hsu, M.-C., Wang, Y., Li, S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60726-6 · Cited by 1,361
A systematic review of worldwide epidemiology of psoriasis
Michalek, I. M., Loring, B., & John, S. M. (2017) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13854 · Cited by 1,150
Reich, K., Nestle, F. O., Papp, K., Ortonne, J.-P., Evans, R., Guzzo, C., Li, S., Dooley, L. T., & Griffiths, C. E. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67566-6 · Cited by 1,045
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics
Menter, A., Strober, B. E., Kaplan, D. H., Kivelevitch, D., Prater, E. F., Stoff, B., Armstrong, A. W., Connor, C., Cordoro, K. M., Davis, D. M. R., et al. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.11.057 · Cited by 969
Self-citationDalgard, F. J., Gieler, U., Tomas-Aragones, L., Lien, L., Poot, F., Jemec, G. B. E., Misery, L., Szabo, C., Linder, D., Sampogna, F., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.530 · Cited by 968
Blauvelt, A., Papp, K. A., Griffiths, C. E. M., Randazzo, B., Wasfi, Y., Shen, Y.-K., Li, S., & Kimball, A. B. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.11.041 · Cited by 897
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
Menter, A., Tyring, S. K., Gordon, K., Kimball, A. B., Leonardi, C. L., Langley, R. G., Strober, B. E., Kaul, M., Gu, Y., Okun, M., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.09.010 · Cited by 889
Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
Griffiths, C. E. M., Strober, B. E., van de Kerkhof, P., Ho, V., Fidelus-Gort, R., Yeilding, N., Guzzo, C., Xia, Y., Zhou, B., Li, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0810652 · Cited by 859
Griffiths, C. E. M., Reich, K., Lebwohl, M., van de Kerkhof, P., Paul, C., Menter, A., Cameron, G. S., Erickson, J., Zhang, L., Secrest, R. J., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60125-8 · Cited by 834
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
Lebwohl, M., Strober, B., Menter, A., Gordon, K., Weglowska, J., Puig, L., Papp, K., Spelman, L., Toth, D., Kerdel, F., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503824 · Cited by 828
Self-citationSaurat, J. ‐., Stingl, G., Dubertret, L., Papp, K. A., Langley, R. G. B., Ortonne, J. ‐., Unnebrink, K., Kaul, M., Camez, A., & for the CHAMPION Study Investigators (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08315.x · Cited by 798
Psoriasis prevalence among adults in the United States
Rachakonda, T. D., Schupp, C. W., & Armstrong, A. W. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.11.013 · Cited by 783
Self-citationMehta, N. N., Azfar, R. S., Shin, D. B., Neimann, A. L., Troxel, A. B., & Gelfand, J. M. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp567 · Cited by 706
Papp, K. A., Tyring, S., Lahfa, M., Prinz, J., Griffiths, C. E. M., Nakanishi, A. M., Zitnik, R., van de Kerkhof, P. C. M., & the Etanercept Psoriasis Study Group (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06688.x · Cited by 693
Papp, K., Reich, K., Leonardi, C. L., Kircik, L., Chimenti, S., Langley, R. G. B., Hu, C., Stevens, R. M., Day, R. M., Gordon, K. B., et al. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.03.049 · Cited by 678
Gordon, K. B., Strober, B., Lebwohl, M., Augustin, M., Blauvelt, A., Poulin, Y., Papp, K. A., Sofen, H., Puig, L., Foley, P., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31713-6 · Cited by 678
A Genome-Wide Association Study of Psoriasis and Psoriatic Arthritis Identifies New Disease Loci
Liu, Y., Helms, C., Liao, W., Zaba, L. C., Duan, S., Gardner, J., Wise, C., Miner, A., Malloy, M. J., Pullinger, C. R., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000041 · Cited by 663
Sequence and Haplotype Analysis Supports HLA-C as the Psoriasis Susceptibility 1 Gene
Nair, R. P., Stuart, P. E., Nistor, I., Hiremagalore, R., Chia, N. V. C., Jenisch, S., Weichenthal, M., Abecasis, G. R., Lim, H. W., Christophers, E., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/503821 · Cited by 606
Reich, K., Papp, K. A., Blauvelt, A., Tyring, S. K., Sinclair, R., Thaçi, D., Nograles, K., Mehta, A., Cichanowitz, N., Li, Q., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31279-5 · Cited by 569
Guidelines of care for the management of psoriasis and psoriatic arthritis
Menter, A., Korman, N. J., Elmets, C. A., Feldman, S. R., Gelfand, J. M., Gordon, K. B., Gottlieb, A. B., Koo, J. Y. M., Lebwohl, M., Lim, H. W., et al. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.03.027 · Cited by 558
Elmets, C. A., Leonardi, C. L., Davis, D. M. R., Gelfand, J. M., Lichten, J., Mehta, N. N., Armstrong, A. W., Connor, C., Cordoro, K. M., Elewski, B. E., et al. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.11.058 · Cited by 503
Self-citationSingh, J. A., Guyatt, G., Ogdie, A., Gladman, D. D., Deal, C., Deodhar, A., Dubreuil, M., Dunham, J., Husni, M. E., Kenny, S., et al. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40726 · Cited by 493
Guidelines of care for the management of psoriasis and psoriatic arthritis
Menter, A., Korman, N. J., Elmets, C. A., Feldman, S. R., Gelfand, J. M., Gordon, K. B., Gottlieb, A., Koo, J. Y. M., Lebwohl, M., Lim, H. W., et al. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.12.032 · Cited by 481
Abuabara, K., Azfar, R. S., Shin, D. B., Neimann, A. L., Troxel, A. B., & Gelfand, J. M. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09941.x · Cited by 472
Armstrong, E. J., Harskamp, C. T., & Armstrong, A. W. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000062 · Cited by 470
Self-citationSingh, J. A., Guyatt, G., Ogdie, A., Gladman, D. D., Deal, C., Deodhar, A., Dubreuil, M., Dunham, J., Husni, M. E., Kenny, S., et al. (2019) · Arthritis Care & Research · doi:10.1002/acr.23789 · Cited by 466
Psoriasis Severity and the Prevalence of Major Medical Comorbidity: A Population-Based Study
Yeung, H., Takeshita, J., Mehta, N. N., Kimmel, S. E., Ogdie, A., Margolis, D. J., Shin, D. B., Attor, R., Troxel, A. B., & Gelfand, J. M. (2013) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.5015 · Cited by 464
Psoriasis and metabolic syndrome: A systematic review and meta-analysis of observational studies
Armstrong, A. W., Harskamp, C. T., & Armstrong, E. J. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2012.08.015 · Cited by 459
Self-citationAhlehoff, O., Gislason, G. H., Charlot, M., Jørgensen, C. H., Lindhardsen, J., Olesen, J. B., Abildstrøm, S. Z., Skov, L., Torp-Pedersen, C., & Hansen, P. R. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02310.x · Cited by 441
The Risk of Stroke in Patients with Psoriasis
Gelfand, J. M., Dommasch, E. D., Shin, D. B., Azfar, R. S., Kurd, S. K., Wang, X., & Troxel, A. B. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.112 · Cited by 439
Dowlatshahi, E. A., Wakkee, M., Arends, L. R., & Nijsten, T. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.508 · Cited by 436
Cyclosporine for Plaque-Type Psoriasis: Results of a Multidose, Double-Blind Trial
Ellis, C. N., Fradin, M. S., Messana, J. M., Brown, M. D., Siegel, M. T., Hartley, A. H., Rocher, L. L., Wheeler, S., Hamilton, T. A., Parish, T. G., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101313240501 · Cited by 429
Mariette, X., Matucci-Cerinic, M., Pavelka, K., Taylor, P., van Vollenhoven, R., Heatley, R., Walsh, C., Lawson, R., Reynolds, A., & Emery, P. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.149419 · Cited by 404
Etanercept Treatment for Children and Adolescents with Plaque Psoriasis
Paller, A. S., Siegfried, E. C., Langley, R. G., Gottlieb, A. B., Pariser, D., Landells, I., Hebert, A. A., Eichenfield, L. F., Patel, V., Creamer, K., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa066886 · Cited by 391
Tsoi, L. C., Stuart, P. E., Tian, C., Gudjonsson, J. E., Das, S., Zawistowski, M., Ellinghaus, E., Barker, J. N., Chandran, V., Dand, N., et al. (2017) · Nature Communications · doi:10.1038/ncomms15382 · Cited by 384
Reich, K., Armstrong, A. W., Langley, R. G., Flavin, S., Randazzo, B., Li, S., Hsu, M.-C., Branigan, P., & Blauvelt, A. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31773-8 · Cited by 381
Self-citationKalb, R. E., Fiorentino, D. F., Lebwohl, M. G., Toole, J., Poulin, Y., Cohen, A. D., Goyal, K., Fakharzadeh, S., Calabro, S., Chevrier, M., et al. (2015) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.0718 · Cited by 373
Psoriasis and the Risk of Diabetes Mellitus: A Systematic Review and Meta-analysis
Armstrong, A. W., Harskamp, C. T., & Armstrong, E. J. (2013) · JAMA Dermatology · doi:10.1001/2013.jamadermatol.406 · Cited by 342
Self-citationEpidemiology and comorbidities of psoriasis patients in a national database in Taiwan
Tsai, T.-F., Wang, T.-S., Hung, S.-T., Tsai, P. I.-C., Schenkel, B., Zhang, M., & Tang, C.-H. (2011) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2011.03.002 · Cited by 323
Blauvelt, A., Reich, K., Tsai, T.-F., Tyring, S., Vanaclocha, F., Kingo, K., Ziv, M., Pinter, A., Vender, R., Hugot, S., et al. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.08.008 · Cited by 312
Reich, K., Gooderham, M., Thaçi, D., Crowley, J. J., Ryan, C., Krueger, J. G., Tsai, T.-F., Flack, M., Gu, Y., Williams, D. A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30952-3 · Cited by 301
Stern, R. S. (2012) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.04.004 · Cited by 300
Comparison of Biologics and Oral Treatments for Plaque Psoriasis: A Meta-analysis
Armstrong, A. W., Puig, L., Joshi, A., Skup, M., Williams, D., Li, J., Betts, K. A., & Augustin, M. (2020) · JAMA Dermatology · doi:10.1001/jamadermatol.2019.4029 · Cited by 294
Self-citationPsoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study
Ahlehoff, O., Gislason, G. H., Jørgensen, C. H., Lindhardsen, J., Charlot, M., Olesen, J. B., Abildstrøm, S. Z., Skov, L., Torp-Pedersen, C., & Hansen, P. R. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr285 · Cited by 246
Psoriasis and suicidality: A systematic review and meta-analysis
Singh, S., Taylor, C., Kornmehl, H., & Armstrong, A. W. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.05.019 · Cited by 234
Self-citationBarker, J., Hoffmann, M., Wozel, G., Ortonne, J.-P., Zheng, H., van Hoogstraten, H., & Reich, K. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10615.x · Cited by 202
Alwan, W., & Nestle, F. O. (2015) · PubMed · Cited by 197
Weinstein, G. D., Krueger, G. G., Lowe, N. J., Duvic, M., Friedman, D. J., Jegasothy, B. V., Jorizzo, J. L., Shmunes, E., Tschen, E. H., Lew-Kaya, D. A., et al. (1997) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(97)70216-0 · Cited by 184
A Susceptibility Gene for Psoriatic Arthritis Maps to Chromosome 16q: Evidence for Imprinting
Karason, A., Gudjonsson, J. E., Upmanyu, R., Antonsdottir, A. A., Hauksson, V. B., Runasdottir, E. H., Jonsson, H. H., Gudbjartsson, D. F., Frigge, M. L., Kong, A., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/345646 · Cited by 180
Lerman, J. B., Joshi, A. A., Chaturvedi, A., Aberra, T. M., Dey, A. K., Rodante, J. A., Salahuddin, T., Chung, J. H., Rana, A., Teague, H. L., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.026859 · Cited by 174
Gottlieb, A., Sullivan, J., van Doorn, M., Kubanov, A., You, R., Parneix, A., Hugot, S., & Milutinovic, M. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.07.058 · Cited by 159
Gottlieb, A. B., Blauvelt, A., Thaçi, D., Leonardi, C. L., Poulin, Y. P., Drew, J., Peterson, L., Arendt, C. H., Burge, D. J., & Reich, K. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.04.012 · Cited by 157
The role of vitamin D in psoriasis: a review
Soleymani, T., Hung, T., & Soung, J. (2015) · International Journal of Dermatology · doi:10.1111/ijd.12790 · Cited by 141
Warren, R. B., Mrowietz, U., von Kiedrowski, R., Niesmann, J., Wilsmann‐Theis, D., Ghoreschi, K., Zschocke, I., Falk, T. M., Blödorn‐Schlicht, N., & Reich, K. (2016) · The Lancet · doi:10.1016/s0140-6736(16)32127-4 · Cited by 139
Bagel, J., Duffin, K. C., Moore, A. Y., Ferris, L. K., Siu, K., Steadman, J., Kianifard, F., Nyirady, J., & Lebwohl, M. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.05.033 · Cited by 119
Diagnosis and treatment of psoriatic arthritis
Mease, P. J., & Goffe, B. S. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.06.013 · Cited by 114
Coronary Artery Disease in Patients With Psoriasis Referred for Coronary Angiography
Armstrong, A. W., Harskamp, C. T., Ledo, L., Rogers, J. H., & Armstrong, E. J. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.11.025 · Cited by 111
Self-citationAssociation Between Skin and Aortic Vascular Inflammation in Patients With Psoriasis
Dey, A. K., Joshi, A. A., Chaturvedi, A., Lerman, J. B., Aberra, T. M., Rodante, J. A., Teague, H., Harrington, C. L., Rivers, J. P., Chung, J. H. N., et al. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.1213 · Cited by 110
Paul, C. F., Griffiths, C. E. M., van de Kerkhof, P. C. M., Puig, L., Dutronc, Y., Henneges, C., Dossenbach, M. R. K., Hollister, K., & Reich, K. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.06.039 · Cited by 103
Tazarotene plus UVB phototherapy in the treatment of psoriasis
Koo, J. Y. M., Lowe, N. J., Lew‐Kaya, D. A., Vasilopoulos, A. I., Lue, J. C., Sefton, J., & Gibson, J. R. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.107940 · Cited by 102
Reich, K., Sullivan, J. R., Arenberger, P., Mrowietz, U., Jazayeri, S., Augustin, M., Parneix, A., Regnault, P., You, R., & Milutinovic, M. (2018) · British Journal of Dermatology · doi:10.1111/bjd.17351 · Cited by 102
Lin, H., Wang, K.-H., Lin, H., & Lin, H. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.01.050 · Cited by 94
Stern, R. S., & Huibregtse, A. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.399 · Cited by 89
Prevalence and Phenotype of Concurrent Psoriasis and Inflammatory Bowel Disease
Eppinga, H., Poortinga, S., Thio, H. B., Nijsten, T. E. C., Nuij, V. J. A. A., van der Woude, C. J., Vodegel, R. M., Fuhler, G. M., & Peppelenbosch, M. P. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001169 · Cited by 85
Comparison of Coronary Artery Calcium Scores Between Patients With Psoriasis and Type 2 Diabetes
Mansouri, B., Kivelevitch, D. N., Natarajan, B., Joshi, A. A., Ryan, C., Benjegerdes, K. E., SCHUSSLER, J. M., Rader, D. J., Reilly, M. P., Menter, A., et al. (2016) · JAMA Dermatology · doi:10.1001/jamadermatol.2016.2907 · Cited by 78
Kimball, A. B., Rothman, K. J., Kricorian, G., Pariser, D. M., Yamauchi, P. S., Menter, A., Teller, C. F., Aras, G. A., Accortt, N. A., Hooper, M. M., et al. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.08.050 · Cited by 73
Psoriasis and risk of diabetes-associated microvascular and macrovascular complications
Armstrong, A. W., Guérin, A., Sundaram, M., Wu, E. Q., Faust, E., Ionescu‐Ittu, R., & Mulani, P. M. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.02.1095 · Cited by 73
Self-citationMenter, A., Thaçi, D., Wu, J. J., Abramovits, W., Kerdel, F. A., Arikan, D., Guo, D., Ganguli, A. X., Bereswill, M., Camez, A. A., et al. (2017) · Dermatology and Therapy · doi:10.1007/s13555-017-0198-x · Cited by 49
Cited by
Griffiths, C. E. M., Armstrong, A. W., Gudjonsson, J. E., & Barker, J. N. W. N. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32549-6 · Cited by 2,383
Self-citationPeng, Y., Ao, M., Dong, B., Jiang, Y., Yu, L., Chen, Z., Hu, C., & Xu, R. (2021) · Drug Design, Development and Therapy · doi:10.2147/dddt.s327378 · Cited by 827
Connelly‐Smith, L., Alquist, C. R., Aqui, N. A., Hofmann, J. C., Klingel, R., Onwuemene, O. A., Patriquin, C. J., Pham, H. P., Sanchez, A. P., Schneiderman, J., et al. (2023) · Journal of Clinical Apheresis · doi:10.1002/jca.22043 · Cited by 684
The signal pathways and treatment of cytokine storm in COVID-19
Yang, L., Xie, X., Tu, Z., Fu, J., Xu, D., & Zhou, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00679-0 · Cited by 603
Signaling pathways and targeted therapies for psoriasis
Guo, J., Zhang, H., Lin, W., Lu, L., Su, J., & Chen, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01655-6 · Cited by 427
Metadata
- Authors
- Armstrong, A. W., & Read, C.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2020-05-19
- Volume
- 323
- Issue
- 19
- Pages
- 1945
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W3028355101
- Cited by
- 2,335
- References
- 73
- FWCI
- 63.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.